← Azimuth Daily
Capturing data…
Capturing data…
FRI, 6 NOV · 97 ITEMS
"MHRA plan to strengthen patient involvement in medicines regulation" — Dept for Business and Trade · United Kingdom
The UK's Medicines and Healthcare products Regulatory Agency () has published a new plan — part of its 2030 Strategy — aimed at giving patients and the public a greater, more formal role in how medicines and medical devices are regulated. This likely includes participation in clinical trial design, benefit-risk assessments, and post-market surveillance, moving beyond mere consultation toward shared decision-making in regulatory processes.
This is a direct official release from the MHRA (via GOV.UK), making it a primary-source claim. The reporting closely matches the government's own announcement of a Patient and Public Involvement and Engagement Plan, so the claim is solid and well-grounded.
Genuinely new — the plan was published on 14 October 2026 as part of the MHRA's 2030 Strategy rollout, and coverage appeared within hours.